Palisade Bio, Inc. (PALI)
2.01
-0.04
(-1.95%)
USD |
NASDAQ |
Sep 10, 16:00
2.05
+0.04
(+1.99%)
After-Hours: 20:00
Palisade Bio Debt to Equity Ratio : 0.00 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.0005 |
| September 30, 2025 | 0.0657 |
| June 30, 2025 | 0.129 |
| March 31, 2025 | 0.0109 |
| December 31, 2024 | 0.0226 |
| September 30, 2024 | 0.054 |
| June 30, 2024 | 0.0506 |
| March 31, 2024 | 0.0182 |
| December 31, 2023 | 0.0326 |
| September 30, 2023 | 0.0354 |
| June 30, 2023 | 0.0428 |
| March 31, 2023 | 0.0212 |
| December 31, 2022 | 0.0324 |
| September 30, 2022 | 0.0557 |
| June 30, 2022 | 0.2315 |
| March 31, 2022 | 0.0136 |
| December 31, 2021 | 0.027 |
| September 30, 2021 | 0.1852 |
| June 30, 2021 | -0.1421 |
| March 31, 2021 | 0.0191 |
| December 31, 2020 | -0.2002 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.01 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.017 |
| December 31, 2019 | 0.0353 |
| September 30, 2019 | 0.0261 |
| June 30, 2019 | 0.0099 |
| March 31, 2019 | 0.0147 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.2588 |
| December 31, 2016 | 0.3271 |
| September 30, 2016 | -1.276 |
| June 30, 2016 | 7.06 |
| March 31, 2016 | -41.40 |
| December 31, 2015 | 1.596 |
| September 30, 2015 | 1.020 |
| June 30, 2015 | 0.6178 |
| March 31, 2015 | 0.4588 |
| December 31, 2014 | 0.4959 |
| September 30, 2014 | 0.2712 |
| June 30, 2014 | 0.265 |
| March 31, 2014 | 0.2618 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
| Alnylam Pharmaceuticals, Inc. | 2.206 |
| Anika Therapeutics, Inc. | 0.1839 |
| Savara, Inc. | 0.2117 |
| Vericel Corp. | 0.2556 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 127.32M |
| Total Liabilities (Quarterly) | 5.567M |
| Shareholders Equity (Quarterly) | 121.75M |
| Current Ratio | 24.25 |
| Net Debt Paydown Yield | 0.00% |